Purpose

To prospectively describe patient-centered and health utilization outcomes through 12 months after cryoneurolysis performed as routine clinical care for chronic pain at Yale.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of chronic pain (generally pain duration of at least 3-6 months) localized to an anatomical region appropriate for cryoneurolysis as determined by the treating physician. - Planned cryoneurolysis procedure as part of standard clinical care. - Ability to provide written informed consent. - Ability and willingness to complete baseline and follow-up questionnaires.

Exclusion Criteria

  • Cryoneurolysis performed as part of a separate investigational trial in which data sharing is not permitted. - Active infection or other clinical contraindication to the procedure as determined by the treating clinician. - Life expectancy of less than 12 months in the judgment of the treating clinician. - Any condition that, in the investigator's opinion, would interfere with study participation or completion of follow-up, such as severe psychiatric instability or active substance use that precludes reliable follow-up

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Participants undergoing cryoneurolysis Participants undergoing cryoneurolysis for chronic pain as part of standard clinical care.

Recruiting Locations

Yale New Haven Health Old Saybrook Medical Center
Old Saybrook, Connecticut 06475

More Details

Status
Recruiting
Sponsor
Yale University

Study Contact

Charles A Odonkor, MD
203-767-1555
charles.odonkor@yale.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.